Martin Jagerhorn – EduTrainCEO & Co-founder
Martin Jagerhorn, CEO & Co-founder, EduTrain
Martin Jagerhorn has over 20 years experience supporting tech companies in the research domain with investments and business development. He cofounded Avedas in 2004 and exited to Thomson Reuters in 2013, where he then lead the business unit for Research Information Management. Today, Martin supports a small portfolio of dynamic and high-growth tech companies, including Morressier, the world’s largest platform for early-stage research that provides unique scientific insights to pharma and universities to help accelerate scientific breakthroughs.
How pharma companies can illuminate research blindspots
There’s a vast, hidden area of research that pharma companies have yet to tap into. In this session, discover how to access a unique source of information on early stage research findings, and use data-driven analytics and market alerts to unlock its full potential.
- Discover how to access breaking research from leading medical conferences around the globe and monitor the latest findings around your drugs and compounds
- Learn how to integrate findings from upstream the research process directly into your data warehouse and use this information to identify thought-leaders
- Stay ahead of your competitors and identify trends in relevant fields by enhancing your business intelligence via analytics sourced from high-profile conferences